Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 1, Pages 72-81
Publisher
SAGE Publications
Online
2016-04-02
DOI
10.1177/1352458516641775
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
- (2016) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
- (2016) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
- (2015) Guillaume Martin-Blondel et al. ACTA NEUROPATHOLOGICA
- Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
- (2015) Catherine Larochelle et al. ANNALS OF NEUROLOGY
- Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report
- (2015) Francesco Patti et al. BMC Neurology
- Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab
- (2015) Lena-Alexandra Beume et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Switching from natalizumab to fingolimod
- (2015) Ludwig Kappos et al. NEUROLOGY
- Update on treatments in multiple sclerosis
- (2015) Laure Michel et al. PRESSE MEDICALE
- Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis
- (2014) R. Ratzer et al. JOURNAL OF NEUROIMMUNOLOGY
- Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients
- (2014) Per Soelberg Sorensen et al. JOURNAL OF NEUROLOGY
- Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report
- (2014) Maria Sepúlveda et al. JOURNAL OF NEUROLOGY
- Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis
- (2014) A. Gueguen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Significant clinical worsening after natalizumab withdrawal: Predictive factors
- (2014) A Vidal-Jordana et al. Multiple Sclerosis Journal
- Fingolimod after natalizumab and the risk of short-term relapse
- (2014) V. G. Jokubaitis et al. NEUROLOGY
- MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study
- (2014) R. J. Fox et al. NEUROLOGY
- Maraviroc and JC Virus–Associated Immune Reconstitution Inflammatory Syndrome
- (2014) Paul S. Giacomini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Switching From Natalizumab to Fingolimod in Multiple Sclerosis
- (2014) Mikael Cohen et al. JAMA Neurology
- Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system
- (2012) Catherine Larochelle et al. BRAIN
- Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases
- (2012) Katherine M. Mullen et al. JOURNAL OF NEUROIMMUNOLOGY
- Lethal multiple sclerosis relapse after natalizumab withdrawal
- (2012) V. Rigau et al. NEUROLOGY
- Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) Imke Metz et al. ACTA NEUROPATHOLOGICA
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- How do immune cells overcome the blood-brain barrier in multiple sclerosis?
- (2011) Catherine Larochelle et al. FEBS LETTERS
- IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB?
- (2010) T. Lenhard et al. NEUROLOGY
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started